MedPath

GEFITINIB SANDOZ 250 MG COMPRIMIDOS RECUBIERTOS CON PELCULA EFG

GEFITINIB SANDOZ 250 MG COMPRIMIDOS RECUBIERTOS CON PELCULA EFG

Commercialized
Register Number

83716

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Dec 28, 2018

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number83716
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

GEFITINIBActive
Quantity: 250 mg
Name: GEFITINIB

ATC CLASSIFICATION (3)

L01E
L01EB
L01EB01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.